To determine whether depressive symptoms are associated with medial temporal lobe atrophy in older people with and without Alzheimer disease (AD).
Method:
A total of 368 memory clinic patients with AD, mild cognitive impairment, and subjective cognitive impairment (SCI) were included. Depressive symptoms were defined as a score of 8 or higher on Cornell Scale for Depression in Dementia or use of antidepressant medications. Magnetic resonance imaging and computer tomography scans were rated for medial temporal lobe atrophy (MTA), using the Scheltens scale. For a subsample (n = 57 patients), hippocampal volume was manually traced.
Results:
Based on visual assessment, AD patients with depressive symptoms had less atrophy of the right medial temporal lobe (odds ratio [OR] for having MTA: 0.39; 95% confidence interval [CI] 0.16-0.99) and decreased scores on Scheltens scale for the left medial temporal lobe (OR: 0.43, 95% CI 0.19-0.96) in comparison to AD patients without depressive symptoms. In the subgroup where manual tracing was used to measure hippocampal volume, people with SCI experiencing depressive symptoms had smaller right (mean difference: 0.28 cm3; P = .005) and left (mean difference 0.32 cm3; P = .002) hippocampal volumes compared to people with SCI who did not have depressive symptoms.
Conclusion:
Hippocampal atrophy was more pronounced among patients having SCI with depressive symptoms, while the medial temporal lobe was less atrophic in patients having AD with depressive symptoms than those without depressive symptoms. These findings suggest that different mechanisms underlie depression in older people with and without AD and may explain some of the inconsistent observations in previous studies.
DinizBSButtersMAAlbertSMDewMAReynoldsCF 3rd. Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry. 2013;202(5):329–335.
2.
EnacheDWinbladBAarslandD. Depression in dementia: epidemiology, mechanisms, and treatment. Curr Opin Psychiatry. 2011;24(6):461–472.
3.
OwnbyRLAcevedoAHarwoodDGBarkerWWDuaraR. Patterns of depression in Spanish- and English-speaking patients with Alzheimer's disease. J Geriatr Psychiatry Neurol. 2008;21(1):47–55.
4.
SaczynskiJSBeiserASeshadriSAuerbachSWolfPAAuR. Depressive symptoms and risk of dementia: the Framingham heart study. Neurology. 2010;75(1):35–41.
5.
LiGWangLYShoferJB. Temporal relationship between depression and dementia: findings from a large community-based 15-year follow-up study. Arch Gen Psychiatry. 2011;68(9):970–977.
6.
SoennesynHOppedalKGreveOJ. White matter hyperintensities and the course of depressive symptoms in elderly people with mild dementia. Dement Geriatr Cogn Dis Extra. 2012;2:97–111.
7.
DumanRSVoletiB. Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents. Trends Neurosci. 2012;35(1):47–56.
8.
KimJJDiamondDM. The stressed hippocampus, synaptic plasticity and lost memories. Nat Rev Neurosci. 2002;3(6):453–462.
9.
GeldenhuysWJVan der SchyfCJ. Role of serotonin in Alzheimer's disease a new therapeutic target?CNS Drugs. 2011;25(9):765–781.
10.
WalshDMSelkoeDJ. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron. 2004;44(1):181–193.
11.
ZubenkoGSMoossyJ. Major depression in primary dementia - clinical and neuropathologic correlates. Arch Neurol. 1988;45(11):1182–1186.
12.
RappMASchnaider-BeeriMGrossmanHT. Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch Gen Psychiatry. 2006;63(2):161–167.
13.
RappMASchnaider-BeeriMPurohitDPPerlDPHaroutunianVSanoM. Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression. Am J Geriatr Psychiatry. 2008;16(2):168–174.
14.
BallmaierMNarrKLTogaAW. Hippocampal morphology and distinguishing late-onset from early-onset elderly depression. Am J Psychiatry. 2008;165(2):229–237.
15.
SteffensDCMcQuoidDRPayneMEPotterGG. Change in hippocampal volume on magnetic resonance imaging and cognitive decline among older depressed and nondepressed subjects in the neurocognitive outcomes of depression in the elderly study. Am J Geriatr Psychiatry. 2011;19(1):4–12.
16.
TsopelasCStewartRSavvaGM. Neuropathological correlates of late-life depression in older people. Br J Psychiatry. 2011;198(2):109–114.
17.
WeberKGiannakopoulosPDelaloyeC. Volumetric MRI changes, cognition and personality traits in old age depression. J Affect Disord. 2010;124(3):275–282.
18.
KohlerSThomasAJLloydABarberRAlmeidaOPO'BrienJT. White matter hyperintensities, cortisol levels, brain atrophy and continuing cognitive deficits in late-life depression. Br J Psychiatry. 2010;196(2):143–149.
19.
CharneyDSManjiHK. Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention. Sci STKE. 2004;2004(225):re5.
20.
JormAF. The informant questionnaire on cognitive decline in the elderly (IQCODE): a review. Int Psychogeriatr. 2004;16(3):275–293.
21.
LiFJiaXFJiaJ. The informant questionnaire on cognitive decline in the elderly individuals in screening mild cognitive impairment with or without functional impairment. J Geriatr Psychiatry Neurol. 2012;25(4):227–232.
22.
WinbladBPalmerKKivipeltoM. Mild cognitive impairment--beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment. J Intern Med. 2004;256(3):240–246.
23.
AlexopoulosGSAbramsRCYoungRCShamoianCA. Cornell scale for depression in dementia. Biol Psychiatry. 1988;23(3):271–284.
24.
AlexopoulosGSAbramsRCYoungRCShamoianCA. Use of the cornell scale in nondemented patients. J Am Geriatr Soc. 1988;36(3):230–236.
25.
KnapskogABBarcaMLEngedalK. A Comparison of the validity of the cornell scale and the MADRS in detecting depression among memory clinic patients. Dement Geriatr Cogn Disord2011;32(4):287–294.
26.
WattjesMPHennemanWJvan der FlierWM. Diagnostic imaging of patients in a memory clinic: comparison of MR imaging and 64-detector row CT. Radiology. 2009;253(1):174–183.
27.
ScheltensPLeysDBarkhofF. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55(10):967–972.
28.
CavallinLBrongeLZhangY. Comparison between visual assessment of MTA and hippocampal volumes in an elderly, non-demented population. Acta Radiol. 2012;53(5):573–579.
29.
MalykhinNVBouchardTPOgilvieCJCouplandNJSeresPCamicioliR. Three-dimensional volumetric analysis and reconstruction of amygdala and hippocampal head, body and tail. Psychiatry Res. 2007;155(2):155–165.
30.
EritaiaJWoodSJStuartGW. An optimized method for estimating intracranial volume from magnetic resonance images. Magn Reson Med. 2000;44(6):973–977.
31.
JackCRTwomeyCKZinsmeisterARSharbroughFWPetersenRCCascinoGD. Anterior temporal lobes and hippocampal formations - normative volumetric measurements from mr images in young-adults. Radiology. 1989;172(2):549–554.
32.
LindbergOOstbergPZandbeltBB. Cortical morphometric subclassification of frontotemporal lobar degeneration. Am J Neuroradiol. 2009;30(6):1233–1239.
33.
WestmanECavallinLMuehlboeckJS. Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease. PLoS One. 2011;6(7):e22506.
34.
StriepensNScheefLWindA. Volume loss of the medial temporal lobe structures in subjective memory impairment. Dement Geriatric Cognitive Disord. 2010;29(1):75–81.
35.
KimMJSeoSWKimGH. Less depressive symptoms are associated with smaller hippocampus in subjective memory impairment. Arch Gerontol Geriatr. 2013;57(1):110–115.
36.
WeisenbachSLBooreLAKalesHC. Depression and cognitive impairment in older adults. Curr Psychiatry Rep. 2012;14(4):280–288.
37.
TrivediMHGreerTL. Cognitive dysfunction in unipolar depression: implications for treatment. J Affect Disord. 2014;152-154:19–27.
38.
KrambergerMGJelicVKareholtI. Cerebrospinal fluid alzheimer markers in depressed elderly subjects with and without Alzheimer's disease. Dement Geriatr Cogn Dis Extra. 2012;2(1):48–56.
39.
RoyallDRPalmerRF. Alzheimer's disease pathology does not mediate the association between depressive symptoms and subsequent cognitive decline. Alzheimers Dement. 2013;9(3):318–325.
40.
GerritsenLComijsHCvan der GraafYKnoopsAJPenninxBWGeerlingsMI. Depression, hypothalamic pituitary adrenal axis, and hippocampal and entorhinal cortex volumes--the SMART Medea study. Biol Psychiatry. 2011;70(4):373–380.
41.
BraakHBraakE. Neuropathological staging of Alzheimer-related changes. Acta Neuropathologica. 1991;82(4):239–259.
42.
BanerjeeSHellierJDeweyM. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet. 2011;378(9789):403–411.
